BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
6/27/2022 9:34:46 AM | Browse: 366 | Download: 848
 |
Received |
|
2021-12-13 07:26 |
|
Peer-Review Started |
|
2021-12-13 07:27 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2022-01-27 08:19 |
|
Revised |
|
2022-02-08 10:07 |
|
Second Decision |
|
2022-06-01 02:58 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2022-06-03 21:46 |
|
Articles in Press |
|
2022-06-03 21:46 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2022-05-18 10:03 |
|
Typeset the Manuscript |
|
2022-06-21 07:35 |
|
Publish the Manuscript Online |
|
2022-06-27 09:34 |
| ISSN |
1948-9366 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Minireviews |
| Article Title |
Transarterial chemoembolization failure/refractoriness: A scientific concept or pseudo-proposition
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Shen Zhang, Bin-Yan Zhong, Lei Zhang, Wan-Sheng Wang and Cai-Fang Ni |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| National Natural Science Foundation of China |
81901847 |
| Natural Science Foundation of Jiangsu Province |
BK20190177 |
| Suzhou Science and Technology Youth Plan |
KJXW2018003 |
|
| Corresponding Author |
Cai-Fang Ni, MD, PhD, Chief Doctor, Department of Interventional Radiology, The First Affiliated Hospital of Soochow University, No. 899 Pinghai Road, Suzhou 215006, Jiangsu Province, China. szncf@suda.edu.cn |
| Key Words |
Hepatocellular carcinoma; Transarterial chemoembolization; Failure; Refractoriness |
| Core Tip |
The definitions in the current concept of transarterial chemoembolization (TACE) failure/refractoriness are not capable of guiding clinical practice. A persistent viable tumor lesion is a well-accepted item of TACE failure/refractoriness, but that is not the case when it comes to new lesions, portal vein tumor thrombosis or extrahepatic spread. Patients with recurrent hepatocellular carcinoma after TACE constitute a heterogenous group and the treatment modalities need to be individualized. |
| Publish Date |
2022-06-27 09:34 |
| Citation |
Zhang S, Zhong BY, Zhang L, Wang WS, Ni CF. Transarterial chemoembolization failure/refractoriness: A scientific concept or pseudo-proposition. World J Gastrointest Surg 2022; 14(6): 528-537 |
| URL |
https://www.wjgnet.com/1948-9366/full/v14/i6/528.htm |
| DOI |
https://dx.doi.org/10.4240/wjgs.v14.i6.528 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
